Ovarian cancer test nearly 100% accurate

Ovarian cancer is a silent killer that displays few obvious symptoms. But researchers from the Georgia Institute of Technology may have the answer for detecting the disease early. In a recent study, they detected ovarian cancer from blood samples with near 100 percent accuracy. "Because ovarian cancer is a disease of relatively low prevalence, it's essential that tests for it be extremely accurate. We believe we may have developed such a test," says John McDonald, chief research scientist at the Ovarian Cancer Institute. Report

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.